Literature DB >> 33517258

Radiation dose reduction in CT-guided cryoablation of renal tumors.

Jim Zhong1, Michael Gallagher1, Chris Hounslow1, Gareth Iball2, Tze Wah1.   

Abstract

PURPOSE: We aimed to evaluate the effect on the radiation dose to the patient by reducing the tube current during the placement of the ablation needles (reduced dose group) compared with the patient doses delivered when scanning at the standard fully diagnostic level (full dose group) in computed tomography (CT)-guided percutaneous cryoablation.
METHODS: We conducted a retrospective study of 103 patients undergoing cryoablation in a tertiary cancer center. Overall, 62 patients were scanned with standard exposure parameters (full dose group) set on a 64-slice multidetector CT scanner, while 41 patients were scanned on a reduced dose protocol. Dose levels were retrieved from the hospital picture and archiving communication system including the volumetric CT dose index (CTDIvol), total dose length product (DLP), length of cryoablation procedure, number of cryoablation needles and patient size. Wilcoxon Mann-Whitney (rank-sum) tests were used to compare the median DLP, CTDIvol and skin dose between the two groups.
RESULTS: Median total DLP for the full dose group was 6025 mGy•cm (1909-13353 mGy•cm) compared with 3391 mGy•cm (1683-6820 mGy•cm) for the reduced dose group. The reduced dose group had a 44% reduction in total DLP and 42% reduction in total CTDIvol (p < 0.001). The estimated skin doses were 384 mGy for the full dose group and 224 mGy for the reduced dose group (42% reduction) (p < 0.001). At 12-month follow-up, the technical success for the full dose (n=62) was 97% with 2 patients requiring a further cryoablation treatment for residual tumor. The technical success for the reduced dose group (n=41) was 100%.
CONCLUSION: CT dose reduction technique during image-guided cryoablation treatment of renal tumors can achieve significant radiation dose reduction whilst maintaining sufficient image quality.

Entities:  

Year:  2021        PMID: 33517258      PMCID: PMC7963384          DOI: 10.5152/dir.2021.19548

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  22 in total

Review 1.  The changing natural history of renal cell carcinoma.

Authors:  A J Pantuck; A Zisman; A S Belldegrun
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

2.  Radiation dose reduction in computed tomography: techniques and future perspective.

Authors:  Lifeng Yu; Xin Liu; Shuai Leng; James M Kofler; Juan C Ramirez-Giraldo; Mingliang Qu; Jodie Christner; Joel G Fletcher; Cynthia H McCollough
Journal:  Imaging Med       Date:  2009-10

3.  Complications following 573 percutaneous renal radiofrequency and cryoablation procedures.

Authors:  Thomas D Atwell; Rickey E Carter; Grant D Schmit; Carrie M Carr; Stephen A Boorjian; Timothy B Curry; R Houston Thompson; A Nicholas Kurup; Adam J Weisbrod; George K Chow; Bradley C Leibovich; Matthew R Callstrom; David E Patterson
Journal:  J Vasc Interv Radiol       Date:  2011-10-28       Impact factor: 3.464

Review 4.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

5.  Image registration of pre-procedural MRI and intra-procedural CT images to aid CT-guided percutaneous cryoablation of renal tumors.

Authors:  Sota Oguro; Kemal Tuncali; Haytham Elhawary; Paul R Morrison; Nobuhiko Hata; Stuart G Silverman
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-25       Impact factor: 2.924

6.  Percutaneous cryoablation of renal masses under CT fluoroscopy: radiation doses to the patient and interventionalist.

Authors:  Jessica K Stewart; Christopher B Looney; Colin D Anderson-Evans; Greta I Toncheva; David R Sopko; Charles Y Kim; Terry T Yoshizumi; Rendon C Nelson
Journal:  Abdom Imaging       Date:  2015-10

7.  The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program.

Authors:  Mike M Nguyen; Inderbir S Gill; Lars M Ellison
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

8.  Radiation exposure from CT-guided ablation of renal masses: effects on life expectancy.

Authors:  Jonathan D Eisenberg; Debra A Gervais; Sarabjeet Singh; Mannudeep K Kalra; Sharjeel H Sabir; Aaron B Paul; Pari V Pandharipande
Journal:  AJR Am J Roentgenol       Date:  2015-02       Impact factor: 3.959

9.  Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study.

Authors:  Paul L Nguyen; Ronald C Chen; Jack A Clark; Robert A Cormack; Marian Loffredo; Elizabeth McMahon; Angela U Nguyen; W Warren Suh; Clare M Tempany; Anthony V D'Amico
Journal:  Brachytherapy       Date:  2009-05-09       Impact factor: 2.362

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  1 in total

1.  A national dose analysis of guided tumor destruction: influence of sex, age, localization and destruction technique used.

Authors:  Matthieu Rojo; Aymeric Hamard; Chris Serrand; Hélène de Forges; Jean-Paul Beregi; Joël Greffier; Julien Frandon
Journal:  Quant Imaging Med Surg       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.